Protections needed for some people who say no to research, study concludes

Although federal regulations provide protections for people who participate in research, protections are also needed for some people who decline to participate and may face harmful repercussions as a result, concludes an article in IRB: Ethics & Human Research.

In addition, the authors say that deception may be necessary and ethically justified as a means for researchers to protect decliners from those who might harm them because they chose not to enroll in a study. People in need of such protections include prisoners and others in vulnerable circumstances.

The article is based on findings from the authors' ongoing study, funded by the National Institute of Mental Health, of what influences prisoners to decide to participate in research. The authors realized it was difficult to ensure that prisoners were voluntarily enrolling in their study, rather than enrolling because they were afraid of negative consequences from prison administrators if they declined.

The first solution the authors devised was to talk with prison administrators about the importance of voluntariness. However, they found that such communication "may not reduce the perception of negative consequences for declining to enroll in a study."

The authors then concluded that deception was ethically justified to protect inmates who did not want to volunteer for their study. They protected these people by giving them the option to stay with the researchers for as long as it would take participants to complete the study. The idea was to make it difficult for corrections staff to distinguish the participants from the decliners.

Four inmates asked for this option "These individuals asserted that they felt coerced by the staff of the facility to participate and believed that if they did not participate, they would be penalized," the authors wrote.

The authors proposed other options for protecting people who decline to volunteer for studies, including having the researchers say that these people did not meet the study's eligibility criteria. "All of the approaches designed to protect decliners obviously involve deception," the authors write. "In our view, the obligation to protect participants (and decliners) from illegitimate sanctions outweighs any obligations to disclose fully the bases for our decision to exclude an individual from a study."

While their study involved prisoners, the authors identified other populations who are vulnerable to harm if they decline to participate in research: students concerned that their grades will be affected if they don't enroll in their professors' studies and patients worried that the quality of their medical care will suffer if they do not enroll in their doctors' studies.

add to favorites email to friend print save as pdf

Related Stories

Reforms needed for compassionate release of prison inmates

Jun 02, 2011

The nation's system of freeing some terminally ill prisoners on grounds of compassionate release is so riddled with medical flaws and procedural barriers that many potentially medically eligible inmates are dying behind bars, ...

High rates of drug-resistant TB among UK prisoners

Mar 16, 2010

UK prisoners are significantly more likely to have drug resistant TB than other people with the disease, suggests research published ahead of print in the Journal of Epidemiology and Community Health.

Care for prisoners will improve public health

Nov 19, 2010

In a comprehensive global survey, researchers in Texas and England have concluded that improving the mental and physical health of inmates will improve public health.

Recommended for you

Hormonal therapy for transsexualism safe and effective

13 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

17 hours ago

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

Getting enough sleep could help prevent type 2 diabetes

Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute (LA BioMed) research findings presented ...

Aspirin may fight cancer by slowing DNA damage

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...